Hélène Sapin

7PUBLICATIONS
31CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsExercise physiologyRehabilitation engineeringAboriginal and Torres Strait Islander theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

|Mar 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.

Andreea Ciudin, Helene Sapin, Ludi Fan

|Nov 04, 2025
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.

Xuan Li, Dachuang Cao, Helene Sapin

|Jul 24, 2025
Improvement in body mass index category was associated with improved cardiometabolic measures and patient-reported outcomes in adults with type 2 diabetes treated with tirzepatide.

Rodolfo J Galindo, Clare J Lee, Sheryl Elaine Allen

|Jul 15, 2024
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6).

Kristina Secnik Boye, Jiat Ling Poon, Laura Fernández Landó

|Sep 13, 2023
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes.

Francesco Giorgino, Bruno Guerci, Martin Füchtenbusch

Pageof 2

Frequent Collaborators

4 joint publications

Kristina Secnik Boye

2 joint publications

Suzanne Williamson

2 joint publications

Clare J Lee

2 joint publications

Sarah Zimner-Rapuch